巨星科技(002444.SZ)延續近期強勢漲逾7% 年內累計漲逾120%
格隆匯10月26日丨巨星科技(002444.SZ)延續近期強勢,現報24.43元創15年6月以來新高,漲幅7.53%,最新總市值262.68億;該股年內累計漲幅逾120%。公司此前公告稱,今年前三季度營收62.76億,同比增27.35%;歸屬於上市公司股東的淨利潤10.94億,同比增50.44%。長城證券指,公司前三季度業績高速增長,跨境電商業務持續快速增長,國際化佈局將進一步強化公司的競爭優勢。我們預測2020-2022年公司的EPS分別為1.06元、1.25元和1.46元,對應PE分別為21.04倍、17.81倍和15.27倍。維持“推薦”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.